U.S. Food and Drug Administration

Get your COVID-19 vaccine or booster today!

Find out where to get a COVID-19 vaccine, test, or treatment in your community. Call 1-800-232-0233 with questions.

COVID.gov

Featured

FDA COVID-19 Response

FDA is working with U.S. government partners, including CDC, and international partners to address the pandemic.

Food

Drugs

Medical Devices

Radiation-Emitting Products

Vaccines, Blood, and Biologics

Animal and Veterinary

Cosmetics

Tobacco Products

LGBTQI+ Health & Well-being

Join us in advancing equality for LGBTQI+ children and families and preventing discrimination against LGBTQI+ people.

Science-related icons juxtoposed on a background of prescription paperwork

Fostering Drug Competition

Increasing the availability of generic drugs helps to create competition in the marketplace, helping make treatment more affordable and increasing access to healthcare for more patients.

New Era of Smarter Food Safety

A new approach to food safety that recognizes and builds on the progress made in the past but looks towards what processes and tools will be needed for the future.

Jul 06

FDA Infant Formula Update: July 6, 2022

Jul 05

FDA Roundup: July 5, 2022

More Press Announcements

Newsroom Meetings Testimony Speeches

Jul 05

Mylan Pharmaceuticals Inc., a Viatris Company, Issues Voluntary Nationwide Recall of One Batch of Insulin Glargine (Insulin glargine-yfgn) Injection Pens, 100 units/mL (U-100), Due to the Potential of Missing Labels on Some Pens

Drugs

Jul 03

Natreve Issues Voluntary Recall on Limited U.S. Batches of Natreve Vegan Protein Powder French Vanilla Wafer Sundae Flavor Due to Undeclared Milk

Food & Beverages

Jun 30

J&M Foods Issues a Voluntary Recall on a Select Lot Number of Lavender Shortbread Cookies Due to the Packages Contain Chocolate Chip Cookies That Do Not Disclose the Correct Allergens

Food & Beverages

More Recalls Market Withdrawals & Safety Alerts Subscribe to the Enforcement Report Mailing List

Paragraph Header

Collage that depicts a variety of medical devices.

FDA’s Center for Devices and Radiological Health’s Continued Efforts to Return to Normal: Reopening for All Pre-Submissions

We continue interactions with device submission sponsors as we work to return to normal operations while continuing to respond to the public health emergency.

Illustration graphic of woman holding pendulum with internet cloud icon, about to let go into other pendulum balls with apple, pills, syringe, and microscope icons. Right side of illustration is the report cover of the Enterprise Modernization Action Plan (EMAP).

FDA's “All-in” Approach to Enterprise Transformation

The Enterprise Modernization Action Plan is the next phase of FDA’s data and technology transformation and describes our plans to shape the agency’s future.

Three image collage depicting a group of lab workers in white coats. Yellow pills being sorted by machinery, and a pharmacist holding a bottle of pills, conversing with a patient.

FDA Seeks to Engage Stakeholders on Key Considerations for a Drug Quality Management Maturity Program

Program Aims to Improve Drug Supply Chain, Mitigate Shortages

Jul 08

CVM GFI #245 Hazard Analysis and Risk-Based Preventive Controls for Food for Animals

Animal & Veterinary

Jul 06

DSCSA Standards for the Interoperable Exchange of Information for Tracing of Certain Human, Finished, Prescription Drugs Guidance for Industry

Drugs

Jul 05